American Journal of Nephrology

Papers
(The TQCC of American Journal of Nephrology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy257
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage74
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review51
Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present41
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial37
Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents34
Starvation Ketosis and the Kidney29
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome29
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis28
New Onset Biopsy-Proven Nephropathies after COVID Vaccination28
The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease26
Machine Learning for Prediction and Risk Stratification of Lupus Nephritis Renal Flare25
Efficacy and Safety of Molidustat for Anemia in ESA-Naive Nondialysis Patients: A Randomized, Phase 3 Trial24
The Forgotten Antiproteinuric Properties of Diuretics22
Molidustat for Renal Anemia in Nondialysis Patients Previously Treated with Erythropoiesis-Stimulating Agents: A Randomized, Open-Label, Phase 3 Study21
Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel18
Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives17
LRG1 Mitigates Renal Interstitial Fibrosis through Alleviating Capillary Rarefaction and Inhibiting Inflammatory and Pro-Fibrotic Cytokines16
Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)16
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease16
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients16
IL-6 Is Associated with Progression of Coronary Artery Calcification and Mortality in Incident Dialysis Patients15
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics15
Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis15
Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review15
Dietary Factors and Prevention: Risk of End-Stage Kidney Disease by Fruit and Vegetable Consumption15
High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study14
Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes14
Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease14
Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)14
Epidemiology and Outcomes of Acute Kidney Diseases: A Comparative Analysis14
Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients13
Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers12
Diagnostic Performance of Office versus Ambulatory Blood Pressure in Kidney Transplant Recipients11
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies11
Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial11
Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population11
Impact of Sleep Duration on Mortality and Quality of Life in Chronic Kidney Disease: Results from the 2007–2015 KNHANES11
Urinary Epidermal Growth Factor: A Promising “Next Generation” Biomarker in Kidney Disease10
Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients10
Prevalence and Outcomes Associated with Hyperuricemia in Hospitalized Patients with COVID-1910
Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia10
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial10
Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System9
Physical Exercise Improves Cognitive Function in Older Adults with Stage 3–4 Chronic Kidney Disease: A Randomized Controlled Trial9
Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients9
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient9
Impact of Polypharmacy on Health-Related Quality of Life in Dialysis Patients9
Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes8
Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based Database8
Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis8
Incidence of Serum Creatinine Monitoring and Outpatient Visit Follow-Up among Acute Kidney Injury Survivors after Discharge: A Population-Based Cohort Study8
Mass Screening Is Associated with Low Rates of Acute Kidney Injury among COVID-19 Patients in Hong Kong8
Predictors of Survival in Chronic Hemodialysis Patients: A 10-Year Longitudinal Follow-Up Analysis8
Trends in Peritoneal Dialysis Technique Survival, Death, and Transfer to Hemodialysis: A Decade of Data from the RDPLF8
CHA<sub>2</sub>DS<sub>2</sub>-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients8
Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis7
Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors7
Cardiovascular Risk Prediction in Chronic Kidney Disease7
The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?7
Congenital Heart Disease in Adults with Autosomal Dominant Polycystic Kidney Disease7
Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort7
Frequency and Severity of Moral Distress in Nephrology Fellows: A National Survey7
Predictors of Kidney Outcomes of Anti-Glomerular Basement Membrane Disease in a Large Chinese Cohort7
Small Intestinal Phosphate Absorption: Novel Therapeutic Implications7
Associations of Serum Uromodulin and Urinary Epidermal Growth Factor with Measured Glomerular Filtration Rate and Interstitial Fibrosis in Kidney Transplantation6
HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety6
Renal Functional Recovery Confounding the Assessment of Contrast Nephropathy: Propensity Score Analysis6
Association between the Estimated Glomerular Filtration Rate and Brain Atrophy in Older Adults6
Preimplantation Genetic Testing for Kidney Disease-Related Genes: A Laboratory’s Experience6
Accuracy of Anti-GBM Antibodies in Diagnosing Anti-Glomerular Basement Membrane Disease: A Systematic Review and Meta-Analysis6
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial6
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists6
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol6
Assessment of Exercise Intolerance in Patients with Pre-Dialysis CKD with Cardiopulmonary Function Testing: Translation to Everyday Practice6
Dietary Omega-3 Fatty Acid Intake and Mortality in CKD Population: A 1999–2014 NHANES Analysis6
Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage6
Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal Anemia5
Transforming Growth Factor-β1/Smad Signaling in Glomerulonephritis and Its Association with Progression to Chronic Kidney Disease5
Association between <b><i>Opisthorchis viverrini</i></b> Infection and Glomerular Disease in Thailand5
Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement5
Impact of Glucose Tolerance and Its Change on Incident Proteinuria: Analysis of a Nationwide Population-Based Dataset5
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism5
Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States5
Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013–20175
Epidemiology of Hypertension among Patients on Peritoneal Dialysis Using Standardized Office and Ambulatory Blood Pressure Recordings5
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan5
0.052587032318115